ليست عنوان مقالات لاتين Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy Plasma spray synthesis of ultra-fine YSZ powder

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy

2

Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during β-blocker therapy: A potential of hormone-guided treatment

3

Plasma brain natriuretic peptide concentration: impact of age and gender

4

Plasma brain natriuretic peptide correlates with infarct size but not with subsequent remodeling in the rat heart

5

Plasma brain natriuretic peptide in athletes

6

Plasma brain natriuretic peptide in obstructive sleep apnea

7

Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction,

8

Plasma brain natriuretic peptide levels, right ventricular volume overload and exercise capacity in adolescents after surgical repair of tetralogy of Fallot

9

Plasma brain natriuretic peptide reflects left ventricular function during percutaneous cardiopulmonary support

10

Plasma Brain Natriuretic Peptide-Guided Therapy Not Yet Justified

11

Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure: The STARS-BNP Multicenter Study Original Research Article

12

Plasma breaking of thin films into nano-sized catalysts for carbon nanotube synthesis

13

Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function Original Research Article

14

Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension

15

Plasma bubble phenomenon in the topside ionosphere Original Research Article

16

Plasma calcium as a surrogate measure for vitellogenin in fathead minnows (Pimephales promelas)

17

Plasma Calprotectin Level as a Potential Biomarker in Different Phases of Pediatric Hemato-Oncological Malignancies: A Pilot Study

18

Plasma can reduce Staphylococcus epidermidis biofilm formation on medical polymers

19

Plasma carburizing process for the low distortion of automobile gears

20

Plasma cardiac natriuretic peptide levels in screening for cardiac disease

21

Plasma Carnitine Levels of Pregnant Adolescents in Labor

22

Plasma carotenoid concentrations in relation to acute respiratory infections in elderly people

23

Plasma carotenoid, α-tocopherol and retinol concentrations and risk of colorectal adenomas: A case-control study in Japan

24

Plasma carotenoids and tocopherols and cognitive function: A prospective study

25

Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women

26

Plasma carotenoids, tocopherols, and antioxidant capacity in a 12-week intervention study to reduce fat and/or energy intakes

27

Plasma catalysis for CO2 decomposition by using different dielectric materials

28

Plasma catalysis with perovskite-type catalysts for the removal of NO and CH4 from combustion exhausts

29

Plasma catalytic conversion of methane into syngas: the combined effect of discharge activation and catalysis

30

Plasma catalytic hybrid processes: gas discharge initiation and plasma activation of catalytic processes

31

Plasma catecholamine metabolites in antidepressant-exacerbated mania and psychosis

32

Plasma cathode TEA Ar laser development

33

Plasma cell differentiation and multiple myeloma

34

Plasma cell differentiation and survival

35

Plasma Cell Dyscrasia; LCDD vs Immunotactoid glomerulopathy

36

Plasma cell granuloma of the lung: Difficulties in diagnosis and prognosis

37

Plasma Cell Immunophenotyping Improve Prognostic Stratification of Multiple Myeloma Patients

38

Plasma Cell Immunophenotyping Improve Prognostic Stratification of Multiple Myeloma Patients

39

Plasma Cell Leukemia

40

Plasma cell proliferation in monoclonal gammopathy: Relations with other biologic variables—Diagnostic and prognostic significance

41

Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis

42

Plasma Changes of Branched-Chain Amino Acid in Patients with Esophageal Cancer

43

Plasma characteristics in pulse-mode plasmas using time-delayed, time-resolved Langmuir probe diagnoses

44

Plasma characteristics of high-altitude cusp for steady southward-dawnward IMF Original Research Article

45

Plasma characteristics of low-k SiOC(–H) films prepared by using plasma enhanced chemical vapor deposition from DMDMS/O2 precursors

46

Plasma characterization and room temperature growth of carbon nanotubes and nano-onions by excimer laser ablation

47

Plasma characterization and technological application of a hollow cathode plasma source with an axial magnetic field

48

Plasma chemical preparation and characterization of perovskite-type mixed oxides

49

Plasma chemical reactions at atmospheric pressure for high efficiency use of hydrocarbon fuels

50

Plasma chemical reactions in C2H2/N2, C2H4/N2, and C2H6/N2 gas mixtures of a laboratory dielectric barrier discharge Original Research Article

51

Plasma chemotactic activity during dipyridamole induced myocardial ischemia

52

Plasma chitotriosidase activity in multiple sclerosis

53

Plasma Chitotriosidase Activity in Patients with β-Thalassemia

54

Plasma Chitotriosidase Activity Is a Marker of Recovery in Transplanted Patients Affected by (BETA)-Thalassemia major

55

Plasma chloroquine concentrations in young and older malaria patients treated with chloroquine

56

Plasma cholecystokinin and its precursors in hepatic cirrhosis

57

Plasma cholesterol and related lipid levels of seemingly healthy public service employees in Kampala, Uganda.

58

Plasma cholesterol-raising potency of dietary free cholesterol versus cholesteryl ester and effect of β-sitosterol

59

Plasma cholesteryl ester synthesis, cholesteryl ester transfer protein concentration and activity in hypercholesterolemic women: effects of the degree of saturation of dietary fatty acids in the fasting and postprandial states

60

Plasma cholesteryl ester transfer and hepatic lipase activity are determinants of low high density lipoprotein cholesterol associated with insulin resistance in type 2 Diabetic and non-diabetic subjects

61

Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in Type II diabetics and normal controls

62

Plasma choline in normal newborns, infants, toddlers, and in very-low–birth-weight neonates requiring total parenteral nutrition

63

Plasma circulating fibrinogen stability and moderate beer consumption

64

Plasma Circulating Terminal Differentiation– Induced Non-Coding RNA Serves as a Biomarker in Breast Cancer

65

Plasma circulatory markers in male and female patients with coronary artery disease

66

Plasma citrulline levels and acute cellular rejection early after small bowel transplantation in pigs

67

Plasma citrulline measurement using UPLC tandem mass-spectrometry to determine small intestinal enterocyte pathology

68

Plasma cleaning and activation of silicon surface in Dielectric Coplanar Surface Barrier Discharge

69

Plasma cleaning of “endless” substrates by use of a tandem dielectric barrier discharge

70

Plasma cleaning of plastic ball grid array package

71

Plasma cleaning of plastic ball grid array package

72

Plasma cleaning technique for the removal of mixed materials

73

Plasma clearance of cholyl-lysyl-fluorescein: a pilot study in humans

74

Plasma clearance of chylomicrons from butterfat is not dependent on saturation: studies with butterfat fractions and other fats containing triacyiglycerols with low or high melting points

75

Plasma clearance of polyfructosan and extracellular body fluid distribution in idiopathic dilated cardiomyopathy and after heart transplantation

76

Plasma clouds associated with Comet P/Borrelly dust impacts

77

Plasma coagulation factors are also non-lipid coronary heart disease risk factors

78

Plasma coagulation response to surfaces with nanoscale chemical heterogeneity

79

Plasma coatings CrAlN and a-C:H for high efficient power train in automobile

80

Plasma Coenzyme Q10 and Tocopherols in Thoroughbred Race Horses: Effect of Coenzyme Q10 Supplementation and Exercise

81

Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer

82

Plasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphism

83

Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin: A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart

84

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

85

Plasma concentration of cadmium, lead and chromium in smokers and nonsmokers in Tripoli, Libya: A comparative study

86

Plasma Concentration of Glucosamine and Chondroitin Sulfate in Horses after an Oral Dose

87

Plasma concentration of leptin and ghrelin in Standardbred foals as related to the age, sex, exercise and training

88

Plasma concentration of organochlorine compounds is associated with age and not obesity

89

Plasma Concentration of SCUBE1, a Novel Platelet Protein, Is Elevated in Patients With Acute Coronary Syndrome and Ischemic Stroke Original Research Article

90

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men

91

Plasma Concentration of Soluble Vascular Cell Adhesion Molecule-1 and Oncoming Cardiovascular Risk in Patients With Unstable Angina Pectoris and Non–ST-Segment Elevation Myocardial Infarction

92

Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk

93

Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease

94

Plasma concentrations of 15-ketodihydro-PGF2α, progesterone, oestrone sulphate, oestradiol-17β and cortisol during late gestation, parturition and the early post partum period in llamas and alpacas

95

Plasma concentrations of asymmetric dimethylarginine (ADMA) in metabolic syndrome

96

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

97

Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia

98

Plasma concentrations of bacterial lipopolysaccharide: A marker of infection or inflammation?

99

Plasma concentrations of endothelins in cirrhosis

100

Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis

101

Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis

102

Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death

103

Plasma concentrations of immunoreactive relaxin activity and progesterone in the pregnant Asian elephant (Elephas maximus)

104

Plasma Concentrations of Inhibin A and FollicleStimulating Hormone Differ Between Cows with Two or Three Waves of Ovarian Follicular Development in a Single Estrous Cycle

105

Plasma concentrations of melengestrol acetate in humans extrapolated from the pharmacokinetics established in in vivo experiments with rats and chimeric mice with humanized liver and physiologically based pharmacokinetic modeling

106

Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial Infarction Original Research Article

107

Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis

108

Plasma concentrations of obese protein in anorexia nervosa

109

Plasma Concentrations of Oral Metronidazole in the Early Post-Laparotomy Periods

110

Plasma Concentrations of Polychlorinated Biphenyls and the Risk of Breast Cancer: A Congener-specific Analysis

111

Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass

112

Plasma concentrations of testosterone, luteinizing hormone, and estrone sulfate in stallions following hemicastration

113

Plasma concentrations of tumour necrosis factor-α and interleukin-6 during burn wound surgery or dressing

114

Plasma concentrations of type II phospholipase A2, cytokines and eicosanoids in patients with burns

115

Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma

116

Plasma concentrations of β-endorphin, adrenocorticotropic hormone, and cortisol in drinking and abstinent chronic alcoholics

117

Plasma condensation and the one component plasma model Original Research Article

118

Plasma confinement and transport

119

Plasma confinement in JET H mode plasmas with H, D, DT and T isotopes

120

Plasma confinement in the GAMMA 10 tandem mirror

121

Plasma confinement in tokamaks with robust torus

122

Plasma confinement studies in LHD

123

Plasma control at JET

124

Plasma control issues for an advanced steady state tokamak reactor

125

Plasma control system for “Day-One” operation of KSTAR tokamak

126

Plasma control system upgrade and increased plasma stability in NSTX

127

Plasma control systems relevant to ITER and fusion power plants

128

Plasma convection in the Earth’s magnetosphere and ionosphere during substorms Original Research Article

129

Plasma convection in the low-latitude mantle of the near-earth magnetosphere Original Research Article

130

Plasma convection in the nightside magnetosphere of Saturn determined from energetic ion anisotropies

131

Plasma copolymer surfaces of acrylic acid/1,7 octadiene: Surface characterisation and the attachment of ROS 17/2.8 osteoblast-like cells

132

Plasma co-polymerized nano coatings – As a biodegradable solid carrier for tunable drug delivery applications

133

Plasma copper and lipid peroxidation in cigarette smokers

134

Plasma copper concentrations in pathological pregnancies

135

Plasma core for commercially feasible reactor

136

Plasma corticosterone and leptin concentration in male and female rats: debatable facts.

137

Plasma corticotropin levels in patients with familial amyloidotic polyneuropathy during liver transplantation

138

PLASMA CORTICOTROPINE RELEASING HORMONE (CRH) LEVEL DIFFERENCE BETWEEN WISTAR RATS EXPOSED TO ACUTE STRESS DUE TO PREDATOR AND TO THE PSYCHOLOGICAL STRESS DEVICE

139

Plasma corticotropin-releasing factor in depressed patients before and after the dexamethasone suppression test

140

Plasma corticotropin-releasing factor in depressive disorders

141

Plasma corticotropin-releasing hormone and unconjugated estriol in human pregnancy: Gestational patterns and ability to predict preterm delivery

142

Plasma cortisol in first episode drug-naïve mania: Differential levels in euphoric versus irritable mood

143

Plasma cortisol levels in response to a cold pressor test did not predict appetite or ad libitum test meal intake in obese women

144

Plasma Cotinine: Stability in Smokers and Validation of Self-Reported Smoke Exposure in Nonsmokers

145

Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients

146

Plasma C-reactive protein concentration is not affected by isocaloric dietary fat reduction

147

Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease

148

Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: Use of statistical modeling to determine reference limits

149

Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lp(a) levels according to thyroid function status

150

Plasma CRP-hs and Ferritin Concentration Related to Kidney Injury in Adult Patients with Beta-thalassemia: A Cross-sectional Study in Vietnam

151

Plasma current and position feedback control in ADITYA Tokamak

152

Plasma current profile diagnostics on FT-2 based on correlation reflectometry measurements of MHD modes

153

Plasma current sustainment after iron core saturation in the STOR-M tokamak

154

Plasma CVD of hard coatings Ti(CNO) using metallo-organic compound Ti(OC3H7)4

155

Plasma cystatin C determinations in a healthy elderly population

156

Plasma cystatin C: a better marker of glomerular filtration rate than creatinine in kidney transplantation

157

Plasma cystatin-C and development of coronary heart disease: The PRIME Study

158

Plasma cysteine and glutathione are independent markers of postmethionine load endothelial dysfunction

159

Plasma cytokine levels in highly stressed children

160

Plasma cytokine levels in patients with severe burn injury-with reference to the relationship between infection and prognosis

161

Plasma cytokine levels: Relationship to early maternal interactions in socially reared vervet monkeys (Cercopithecus aethiops sabaeus)

162

Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy

163

Plasma cytokines profile in older subjects with late onset Alzheimer’s disease or vascular dementia

164

Plasma Cytokines Profile in Subjects with Alzheimer’s Disease: Interleukin 1 Alpha as a Candidate for Target Therapy

165

Plasma cytokines, acute phase proteins and cortisol in major depression

166

Plasma D-Dimer as a Marker of Urinary Tract Infection in Children

167

Plasma D-dimer Concentration in Horses with Colic

168

Plasma D-Dimer Levels Correlated With Advanced Breast Carcinoma in Female Patients: A Prospective Study at Baghdad Teaching Hospital

169

Plasma decoloration of dye using dielectric barrier discharges with earthed spraying water electrodes

170

Plasma degradation of dyes in water with contact glow discharge electrolysis

171

Plasma dehydroepiandrosterone levels are strongly increased in schizophrenia

172

Plasma densification of agglomerated Cr2O3 powder for thermal spray coating

173

Plasma density behavior with new graphite limiters in HT-7

174

Plasma density induced formation of nanocrystals in physical vapor deposited carbon films Original Research Article

175

‎Plasma density role on instability growth of transverse-longitudinal coupled electromagnetic modes in the collisional dense plasma

176

Plasma density variations observed on a satellite possibly related to seismicity Original Research Article

177

Plasma density-electric field turbulence in the low-latitude ionosphere from the observation on satellites; possible connection with seismicity

178

Plasma deoxycholic acid is related to deoxycholic acid in faecal water

179

Plasma deposited acrylic acid coatings: Surface characterization and attachment of 3T3 murine fibroblast cell lines

180

Plasma deposited coatings for biomedical materials and devices: Fluorocarbon and PEO-like coatings

181

Plasma deposition of acrylamide onto novel aromatic polyamide membrane for pervaporation

182

Plasma deposition of boron films with high growth rate and efficiency using carborane

183

Plasma deposition of hydrogenated diamond-like carbon films from CH4-Ar mixtures

184

Plasma deposition of La0.8Sr0.2MnO3 thin films on yttria-stabilized zirconia from aerosol precursor

185

Plasma deposition of organosilicon polymer thin films with embedded nanosilver for prevention of microbial adhesion

186

Plasma deposition of tetraethoxysilane on polycarbonate membrane for pervaporation of tetrafluoropropanol aqueous solution

187

Plasma Deposition of Thin Carbon Germanium Alloy Films from Organogermanium Compounds

188

Plasma deposition of thin film silicon: kinetics monitored by optical emission spectroscopy

189

Plasma deposition processes from acrylic/methane on natural fibres to control the kinetic release of lysozyme from PVOH monolayer film Original Research Article

190

Plasma derived versus biotechnological manufactured medicine

191

Plasma detection and control requirements for CO2 laser cutting

192

Plasma Dexamethasone Concentration and Cortisol Response during Manic Episodes

193

Plasma diagnosis by recognizing in situ data using a modular backpropagation network

194

Plasma diagnostic on a low-flow plasma for inductively coupled plasma optical emission spectrometry

195

Plasma diagnostic on a low-flow plasma for inductively coupled plasma optical emission spectrometry

196

Plasma diagnostical comparison of the MSIP process of (Ti,Al)N with pulsed and dc power supplies using energy-resolved mass spectroscopy

197

Plasma diagnostics and physics in the W7-AS stellarator

198

Plasma diagnostics and simulation for the SMART-1 mission

199

Plasma diagnostics as a tool for the modeling and simulation of sputter processes

200

Plasma diagnostics at Aditya Tokamak by two views visible light tomography

201

Plasma diagnostics by detecting the ion flux profile to a biased-target

202

Plasma diagnostics during laser ablation in a cavity

203

Plasma diagnostics for pulsed-dc plasma-polymerizing para-xylene using QMS and OES

204

Plasma diagnostics in a double inductively coupled source (DICP) for plasma sterilisation

205

Plasma diagnostics in a large helical device

206

Plasma Diagnostics in JFT-2M

207

Plasma diagnostics in pulsed laser deposition of GaLaS chalcogenides

208

Plasma diagnostics in the pulse magnetron sputtering system used for deposition Ti-C:H thin films

209

Plasma diagnostics of hybrid magnetron sputtering and pulsed laser deposition

210

Plasma diagnostics of pulsed d.c. glow discharge combined with ICP for deep nitriding process

211

Plasma diagnostics using millimetre wave two-dimensional imaging array

212

Plasma Diamine Oxidase Activities in Renal Dialysis Patients, a Human with Spontaneous Copper Deficiency and Marginally Copper Deficient Rats

213

Plasma diffusion and relaxation in a magnetic field

214

Plasma display panel with Ne+N/sub 2/ gas-mixture discharges

215

Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys

216

Plasma disposition and tissue depletion of chlortetracycline in the food producing animals, chickens for fattening

217

Plasma disposition and tissue depletion of difloxacin and its metabolite sarafloxacin in the food producing animals, chickens for fattening

218

Plasma dissociation of H2S with O2 addition

219

Plasma distribution and SnO2 coating deposition using a rectangular filtered vacuum arc plasma source

220

Plasma distribution functions in plasmoids: GEOTAIL observations Original Research Article

221

Plasma distribution in the slender bore excited by coaxial rf electrode

222

Plasma D-lactate Levels in Necrotizing Enterocolitis in Premature Infants

223

Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours

224

Plasma DNA Concentration as an Early Predictor of Outcome in Critically-Ill Septic Patients

225

Plasma doping for the fabrication of ultra-shallow junctions

226

Plasma d-penicillamine redox state evaluation by capillary electrophoresis with laser-induced fluorescence

227

Plasma driven tritium uptake and leakage through plasma facing materials

228

Plasma dry etched p-silicon micromolds for permalloy microstructure array electrodeposition

229

Plasma dry reforming of methane in an atmospheric pressure AC gliding arc discharge: Co-generation of syngas and carbon nanomaterials

230

Plasma duplex treatment of stellite

231

Plasma dynamics and structural modifications induced by femtosecond laser pulses in quartz

232

Plasma dynamics as a key to successful upscaling of pulsed plasma processes

233

Plasma dynamics study by fast imaging and Sm1−xNdxNiO3 thin film deposition

234

Plasma edge cross-field transport: experiment and theory

235

Plasma edge fluid models for recycling at near tangential surfaces

236

Plasma effect in silicon charge coupled devices (CCDs)

237

Plasma effect in silicon charge coupled devices (CCDs)

238

Plasma effect in tape helix traveling-wave tube

239

Plasma effects for heavy ions in implanted silicon detectors

240

Plasma effects for heavy ions in implanted silicon detectors

241

Plasma elaboration of barrier layers: a study of the oxides formed at the surface of brass (90Cu10Zn) by RF electric discharges in oxygen

242

Plasma electrochemical growth of ion-conducting AgBr and AgCl

243

Plasma electrolyte oxidation of hydroxyapatite-containing coating on AZ31B Mg alloy: Effects of current density and duty cycle

244

Plasma Electrolyte, Protein and Metabolite Levels in Nigerian White Fulani Cattle under Two Different Management Systems

245

Plasma electrolytic deposition of titanium dioxide nanorods and nano-particles

246

Plasma electrolytic oxidation and corrosion protection of Zircaloy-4

247

Plasma electrolytic oxidation coating of synthetic Al–Mg binary alloys

248

Plasma electrolytic oxidation coating on AZ91 magnesium alloy modified by neodymium and its corrosion resistance

249

Plasma electrolytic oxidation of 2024-T3 aluminum alloy and investigation on microstructure and wear behavior

250

Plasma electrolytic oxidation of a zirconium alloy under AC conditions

251

Plasma electrolytic oxidation of aluminium networks to form a metal-cored ceramic composite hybrid material

252

Plasma electrolytic oxidation of AM60 magnesium alloy: Monitoring by acoustic emission technique. Electrochemical properties of coatings

253

Plasma electrolytic oxidation of titanium in heteropolytungstate acids

254

Plasma electrolytic surface carburizing and hardening of pure iron

255

Plasma Electron Capture Dissociation for the Characterization of Large Proteins by Top Down Mass Spectrometry

256

Plasma electron temperature diagnostics using semiconductor x-ray detector data analysed by a new theory on the x-ray responses

257

Plasma electron temperature variability in lunar surface potential and in electric field under average solar wind conditions Original Research Article

258

Plasma electrons in Saturnʹs magnetotail: Structure, distribution and energisation

259

Plasma electroplating Ni coating on pure copper sheet—the effects of H2SO4 concentration on the microstructure and mechanical properties

260

Plasma emission diagnostics for the transition from microcrystalline to amorphous silicon solar cells

261

Plasma emission mechanism for radio spikes from solar flares Original Research Article

262

Plasma endothelin and early coronary endothelial dysfunction in recipients of a cardiac transplant

263

Plasma endothelin is increased in early essential hypertension

264

Plasma endothelin levels in patients with cirrhosis

265

Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function

266

Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems

267

Plasma endothelin-1 and thrombomodulin levels in coronary sinus during right atrial pacing and percutaneous transluminal coronary angioplasty

268

Plasma endothelin-1 and tumor necrosis factor-α concentrations in pregnant and cyclic rats after low-dose endotoxin infusion, ,

269

Plasma endothelin-1 in patients with left-to-right shunt

270

Plasma endothelin-1 levels after coronary stenting in humans

271

Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms, ,

272

Plasma endothelin-1 levels in patients with left-to-right shunt with or without pulmonary hypertension

273

Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis

274

Plasma endothelin-I and total insulin exposure in diabetes mellitus

275

Plasma endotoxin and tumor necrosis factor-α in the hyperkinetic state of cirrhosis

276

Plasma energy transport to an electrically biased surface

277

Plasma enhanced aerosol–gel deposition of Al2O3 coatings

278

Plasma enhanced atomic layer deposition of copper: A comparison of precursors

279

Plasma enhanced atomic layer deposition of magnesium oxide as a passivation layer for enhanced photoluminescence of ZnO nanowires

280

Plasma enhanced catalytic reforming of biomass tar model compound to syngas

281

Plasma enhanced chemical vapor deposition of low dielectric constant SiCFO thin films

282

Plasma enhanced chemical vapor deposition of silicon thin films for large area electronics

283

Plasma enhanced chemical vapor deposition of TiO2 films on silica gel powders at atmospheric pressure in a circulating fluidized bed reactor

284

Plasma enhanced chemical vapor deposition of ZnO thin films

285

Plasma enhanced chemical vapour deposition of BCxNy films prepared from N-trimethylborazine: Modelling, synthesis and characterization

286

Plasma enhanced chemical vapour deposition of silica onto titanium: Analysis of surface chemistry, morphology and hydroxylation

287

Plasma enhanced chemical vapour deposition of SiO N in an x y integrated distributed electron cyclotron resonance reactor

288

Plasma enhanced CVD deposition of titanium oxide for biomedical applications

289

Plasma enhanced CVD of fluorocarbon films by low-pressure dielectric barrier discharge

290

Plasma enhanced CVD of SiOxCyHz thin film on different textile fabrics: Influence of exposure time on the abrasion resistance and mechanical properties

291

Plasma enhanced growth of single walled carbon nanotubes at low temperature: A reactive molecular dynamics simulation Original Research Article

292

Plasma enhanced magnetron sputter deposition of Ti–Si–C–N based nanocomposite coatings

293

Plasma enhanced surface treatments using electron beam-generated plasmas

294

Plasma enhanced-CVD of undoped and fluorine-doped Co3O4 nanosystems for novel gas sensors

295

Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions

296

Plasma environment of a weak comet – Predictions for Comet 67P/Churyumov–Gerasimenko from multifluid-MHD and Hybrid models

297

Plasma environment of comet Wirtanen during its low-activity stage

298

Plasma environment of Jupiter family comets

299

Plasma enzymatic, biochemical and hormonal responses to clove oil, 2-phenoxy ethanol, and MS-222 exposed to Caspian brown trout (Salmo trutta caspius, kessleri)

300

Plasma Equilibrium in Tokamaks

301

Plasma erosion in the Venus nightside ionosphere Original Research Article

302

Plasma esterase activities in young and old patients undergoing open inguinal hernia repair

303

Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography–mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy Original Research Article

304

Plasma estrone sulphate (E1S) and estradiol-17β (E2β) profiles during pregnancy and their relationship with the relaxation of sacrosciatic ligament, and prediction of calving time in Holstein–Friesian cattle

305

Plasma etching and feature evolution of organic low-k material by using VicAddress Original Research Article

306

Plasma etching and plasma physics experiments for the undergraduate microelectronics course

307

Plasma etching of As2S3 films for optical waveguides

308

Plasma etching of InGaP, AlInP and AlGaP in BCl3 environments

309

Plasma etching of InGaP, AlInP and AlGaP in BCl3 environments

310

Plasma etching of magnetic multilayers — effect of concurrent UV illumination

311

Plasma etching of magnetic multilayers — effect of concurrent UV illumination

312

Plasma etching: principles, mechanisms, application to micro- and nano-technologies

313

Plasma Evolutions Around a Solar Coronal 3D Magnetic Null Point

314

Plasma exchange and hemodialysis for severe manifestations of multiple wasp stings in a child

315

Plasma exchange in Goodpasture syndrome associated with Turner’s syndrome: A case report

316

Plasma exchange in Kawasaki disease

317

PLASMA EXCHANGE IN PATIENTS WITH THE DIAGNOSIS OF GUILLAIN-BARRE SYNDROME: AN EXPERIENCE IN INTENSIVE CARE UNIT

318

Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature

319

Plasma experiments with relevance for the nonlinear behavior of semiconductors

320

Plasma extraction in a capillary-driven microfluidic device using surfactant-added poly(dimethylsiloxane)

321

Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age

322

Plasma facing and high heat flux materials – needs for ITER and beyond

323

Plasma facing components of EAST

324

Plasma fatty acid changes in rats after long term fructose diet administration

325

Plasma Fatty Acid Composition and 6-Year Incidence of Hypertension in Middle-aged Adults The Atherosclerosis Risk in Communities (ARIC) Study

326

Plasma Fatty Acid Composition and 6-Year Incidence of Hypertension in Middle-aged Adults The Atherosclerosis Risk in Communities (ARIC) Study

327

Plasma fatty acid status in Moroccan children: increased lipid peroxidation and impaired polyunsaturated fatty acid metabolism in protein-calorie malnutrition

328

Plasma fatty acids concentrations in postoperative patients with biliary atresia

329

Plasma fatty-acid composition and antioxidant capacity in low birth-weight infants fed formula enriched with n−6 and n−3 long-chain polyunsaturated fatty acids from purified phospholipids

330

Plasma feedback controller reorganisation for ASDEX Upgradeʹs new discharge control and data acquisition system

331

Plasma ferritin and pregnancy outcome, , ,

332

Plasma ferritin, premature rupture of membranes, and pregnancy outcome, , ,

333

Plasma Fibrinogen and D-dimer in Children With Sepsis: A Single-center Experience

334

Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm

335

Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina

336

Plasma fibrinogen concentration in a Chinese population

337

Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study

338

PLASMA FIBRINOGEN LEVEL IN DIABETICS WITH COMPLICATIONS – A PROSPECTIVE STUDY

339

Plasma fibronectin in French centenarians

340

Plasma Fibronectin in Saliva of Women with History of Miscarriage(s) and Periodontal Disease - a Pilot Study

341

Plasma fibronectin levels in ischemic heart disease

342

Plasma flow across the cusp-magnetosheath boundary under northward IMF Original Research Article

343

Plasma flow measurement in high- and low-field-side SOL and influence on the divertor plasma in JT-60U

344

Plasma flow over an array of particles

345

Plasma flow simulation in an off-plane double bend magnetic filter

346

Plasma flow variations and energetic protons upstream of the earth’s bow shock: A statistical study Original Research Article

347

Plasma flow velocity measurements using a modulated Michelson interferometer

348

Plasma Fluoride Level and Femoral Bone Mineral Density in Post-Menopausal Women

349

Plasma focus assisted damage studies on tungsten

350

Plasma folate as marker of folate status in epidemiological studies: the European Investigation into Cancer and Nutrition (EPIC)-Potsdam study

351

Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility

352

Plasma Fractionation in Malaysia

353

Plasma Fractionation Industry Project in Turkey: Country’s Experiences

354

Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine

355

Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet

356

Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study

357

Plasma Free Fatty Acids and Risk of Atrial Fibrillation (from the Cardiovascular Health Study)

358

Plasma free iron and chemotherapy toxicity

359

Plasma frequency approach to estimate the Debye temperature of the ionic crystals and metal alloys Original Research Article

360

Plasma from patients exposed to ischemia reperfusion contains clastogenic factors and stimulates the chemiluminescence response of normal leukocytes

361

Plasma from preeclamptic women increases human endotheial cell prostacyclin production without changes in cellular enzyme activity or mass,

362

Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein

363

Plasma fullerene production from powdered carbon black Original Research Article

364

Plasma functionalization for improving dispersion and interfacial bonding of multi-wall carbon nanotubes in cyanate ester/epoxy nanocomposites

365

Plasma functionalization of polypropylene with acrylic acid

366

Plasma functionalization of silicon carbide crystalline nanoparticles in a novel low pressure powder reactor

367

Plasma functionalization of titanium surface for repulsion of blood platelets

368

Plasma GABA in children and adolescents with mood and behavior diorders

369

Plasma GABA predicts acute response to divalproex in mania

370

Plasma GABA predicts response to divalproex in mania

371

Plasma gasification of sewage sludge: Process development and energy optimization

372

Plasma gasification process: Modeling, simulation and comparison with conventional air gasification

373

Plasma generation of supported metal catalysts Original Research Article

374

Plasma Ghrelin Concentration and Obesity: The Effect of Smoked Drugs

375

Plasma ghrelin level in children with type 1 diabetes mellitus

376

Plasma Glucagon-Like Peptide-1 (7-36) Amide (GLP-1) Response to Liquid Phase, Solid Phase, and Meals of Differing Lipid Composition

377

Plasma Glucose Alone Does Not Predict Neurologic Dysfunction in Hypoglycemic Nondiabetic Subjects, ,

378

PLASMA GLUCOSE CONCENTRATION AND LIPID PROFILE IN STREPTOZOTOCIN-INDUCED DIABETIC RATS TREATED WITH EXTRACTS OF TRIPLOCHITON SCLEROXYLON K. SCHUM.

379

Plasma glucose, insulin, free fatty acids, lactate and cortisol concentrations in dexmedetomidine-sedated dogs with or without MK-467: A peripheral α-2 adrenoceptor antagonist

380

Plasma glucose, lactate, sodium, and potassium levels in children hospitalized with acute alcohol intoxication

381

Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: The effect of riluzole treatment

382

Plasma glutamine response to enteral administration of glutamine in human volunteers (free glutamine versus protein-bound glutamine)

383

Plasma glutathione peroxidase in healthy young adults: influence of gender and physical activity

384

Plasma glutathione S-transferase Alpha 1-1: A more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy, , , ,

385

Plasma Glycated Albumin Levels Clearly Detect Hearing Loss and Atherosclerosis in Patients with Impaired Fasting Glucose

386

Plasma Glycosaminoglycans: A new Promising tool for Assessment of Non-Metastatic Renal Cell Carcinoma Patients Following Nephrectomy

387

Plasma gonadotropins and ovarian hormones during the estrous cycle in high compared to low ovulation rate gilts

388

Plasma gossypol dynamics in white-tailed deer: Implications for whole cottonseed as a supplemental feed

389

Plasma grafting montmorillonite/iron oxide composite with β-cyclodextrin and its application for high-efficient decontamination of U(VI)

390

Plasma granulysin concentrations and preeclampsia risk

391

Plasma grid design for optimized filter field configuration for the NBI test facility ELISE

392

Plasma Growth Hormone and Prolactin Levels in Healthy Sedentary Young Men after Short-Term Endurance Training under Hot Environment

393

Plasma heating and current drive systems for the fusion ignition research experiment (FIRE)

394

Plasma Heating by Neutral Beam Injection

395

Plasma heating in the initial phase of solar flares

396

Plasma Hepatitis C Virus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province, China

397

Plasma high sensitivity C-reactive protein as a marker of severity in children with diabetic ketoacidosis

398

Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease

399

Plasma homocyst(e)ine, folate and vitamin B12 levels among school children in Taiwan: The Taipei Children Heart Study

400

Plasma homocysteine and all-cause mortality in diabetes

401

Plasma homocysteine and cardiovascular disease mortality

402

Plasma homocysteine and cardiovascular risk factors in African American women

403

Plasma homocysteine and folate are related to arterial blood pressure in type 2 diabetes mellitus

404

Plasma homocysteine and heart disease

405

Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study

406

Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals: The Hoorn Study

407

Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease

408

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus

409

Plasma homocysteine concentration and blood pressure in young adult African Americans

410

Plasma homocysteine concentration is decreased by dietary intervention

411

Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation, ,

412

Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects

413

Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men Original Research Article

414

Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism

415

Plasma homocysteine concentrations do not influence craving in alcohol withdrawal

416

Plasma homocysteine concentrations in a Belgian school-age population

417

Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal

418

PLASMA HOMOCYSTEINE CONCENTRATIONS IN YOUNG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

419

Plasma homocysteine in 80-year-olds: Relationships to medical, psychological and social variables

420

Plasma homocysteine in families of type 1 diabetic patients

421

Plasma homocysteine in subjects with familial combined hyperlipidemia

422

Plasma homocysteine is a determinant of tissue necrosis factor-α in hypertensive patients

423

Plasma Homocysteine Is Not Involved in the Thrombotic Risk of (beta)Thalassemia major Patients

424

Plasma Homocysteine Level and Coronary Artery Disease in Type 2 Diabetic Patients without Nephropathy

425

Plasma Homocysteine Level and Its Genotypes as a Risk Factor for Coronary Artery Disease in Patients Undergoing Coronary Angiography

426

Plasma Homocysteine Level and its Relationship to Clinical Profile in Parkinson’s Disease Patients at the Lagos University Teaching Hospital

427

Plasma homocysteine level and the course of ischemic stroke

428

Plasma homocysteine level in cardiac syndrome X and its relation with duke treadmill score

429

Plasma Homocysteine Level in Patients with Behcet’s Disease with or without Thrombosis

430

Plasma homocysteine levels and cognitive status in long-term stay geriatric patients: a cross-sectional study

431

Plasma homocysteine levels and heart disease

432

Plasma homocysteine levels and heart disease

433

Plasma homocysteine levels and late outcome after coronary angioplasty

434

Plasma homocysteine levels in cardiovascular disease, malaria and protein–energy malnutrition in Sudan

435

Plasma homocysteine levels in cycling, pregnant, and spayed bitches

436

Plasma homocysteine levels in obese and non-obese subjects with or without hypertension; its relationship with oxidative stress and copper

437

Plasma homocysteine levels in patients with isolated coronary artery ectasia

438

Plasma Homocysteine Measurement with Ion Exchange Chromatography (Jeol Aminotac 500): A Comparison with the Abbott IMx Assay

439

Plasma homocysteine predicts progression of atherosclerosis

440

Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia

441

Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women

442

Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal

443

Plasma homovanillic acid concentrations in catatonia

444

Plasma homovanillic acid in the prodromal phase of schizophrenia

445

Plasma homovanillic acid in untreated schizophrenia — relationship with symptomatology and sex

446

Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: Comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance

447

Plasma homovanillic acid profile at different phases of the ovulatory cycle in healthy women

448

Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling

449

Plasma hydrophilic surface treatment for dehumidifying heat exchangers

450

Plasma hydroxyurea determined by gas chromatography–mass spectrometry

451

Plasma IGF-2 Concentration and Tissue Expression in Dogs with Malignant Mammary Tumor

452

Plasma IGF-I levels and cognitive performance in older women

453

Plasma IL-10 Concentration and Its Role in the Pathogenesis of Acute Myeloid Leukemia: a Prospective Study

454

Plasma imaging and spectroscopy diagnostics developed on 100-500-kA pulsed power devices

455

Plasma immersion ion implantation based on glow discharge with electrostatic confinement of electrons

456

Plasma immersion ion implantation experiments at the Instituto Nacional de Pesquisas Espaciais (INPE), Brazil

457

Plasma immersion ion implantation experiments with long and short rise time pulses using high voltage hard tube pulser

458

Plasma immersion ion implantation for shallow junctions in silicon

459

Plasma immersion ion implantation in arc and glow discharge plasmas submitted to low magnetic fields

460

Plasma immersion ion implantation induced improvements of mechanical properties, wear resistance, and adhesion of diamond-like carbon films deposited on tool steel

461

Plasma immersion ion implantation into cylindrical bore using internal inductively-coupled radio-frequency discharge

462

Plasma immersion ion implantation of cold-work steel

463

Plasma immersion ion implantation of complex-shaped objects: an experimental study on the treatment homogeneity

464

Plasma immersion ion implantation of cylindrical bore using self-excited radio-frequency glow discharge

465

Plasma immersion ion implantation of industrial gears

466

Plasma immersion ion implantation of insulating materials

467

Plasma immersion ion implantation of nitrogen in Si: formation of SiO2, Si3N4 and stressed layers under thermal and sputtering effects

468

Plasma immersion ion implantation of nitrogen on austenitic stainless steel at variable energy for enhanced corrosion resistance

469

Plasma immersion ion implantation of poly(tetrafluoroethylene)

470

Plasma immersion ion implantation of polymers and silver–polymer nano composites

471

Plasma immersion ion implantation of TiAl using chlorine containing plasma

472

Plasma immersion ion implantation treatment of medical implants

473

Plasma immersion ion implantation using polymeric substrates with a sacrificial conductive surface layer

474

Plasma immersion ion implantation using titanium and oxygen ions

475

Plasma immersion ion implantation—a fledgling technique for semiconductor processing

476

Plasma immersion ion implanted Ti–B-based coatings: Tribological behaviour at room and high temperatures

477

Plasma immersion low-energy-ion bombardment of naked DNA

478

Plasma immersion N and N+C implantation into high-speed tool steel: surface morphology, phase composition and mechanical properties

479

Plasma immersion nitrogen implantation into silicon and rapid thermal electron beam annealing for surface structuring

480

Plasma immunoglobulins in patients with severe ovarian hyperstimulation syndrome

481

Plasma immunoreactive endothelin-1 levels in hypertensive rats and human subjects

482

Plasma impurity content, gas fueling, and exhaust on DIII-D over extended periods between boronizations

483

Plasma in a high-frequency electric field with a reflective condition on the boundary

484

Plasma in Saturnʹs nightside magnetosphere and the implications for global circulation

485

Plasma inactivation of Escherichia coli cells by atmospheric pressure air brush-shape plasma

486

Plasma induced effects within the bulk material of wood veneers

487

Plasma induced grafting of PSt onto titanium dioxide powder. II

488

Plasma induced patterning of polydimethylsiloxane surfaces

489

Plasma induced sp2 to sp3 transition in boron nitride

490

Plasma Influence of Surface Texture of Silicone Rubber for Biomedical Application in Scala Tympani

491

Plasma Inorganic Iodine and Thyroxine Concentrations for Beef Cows in Late Pregnancy and Early Lactation Associated with Different Levels of Dietary Iodine Supplementation

492

Plasma Insulin and Carotid Intima Media Thickness in Hypertensive and Non Hypertensive Type 2 Diabetics

493

Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice

494

Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men

495

Plasma Insulin-like Growth Factor 1 Distribution and Its Relation to Blood Pressure in Adolescents : The Bogalusa Heart Study

496

Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside

497

Plasma insulin-like growth factor-1 elevated in mild-to-moderate but not severe heart failure

498

Plasma interaction processes during the pulsed laser deposition of superconducting thin films

499

Plasma interaction with liquid lithium: Measurements of retention and erosion

500

Plasma interactions of exoplanets with their parent star and associated radio emissions

501

Plasma interactions with the outboard chamber wall in DIII-D

502

PLASMA INTERFERENCE IN AN ENZYME-LINKED IMMUNOSORBANT ASSAY USING A COMMERCIAL MATCHED ANTIBODY PAIR

503

Plasma interferometry and how the bound-electron contribution can bend fringes in unexpected ways

504

Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6

505

Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

506

Plasma Interleukin-1β and Tumor Necrosis Factor Concentrations in Obsessive–Compulsive Disorders

507

Plasma interleukin-2 levels and thyroid function in elderly patients with nonthyroidal illness

508

Plasma interleukin-22 and its cellular receptor (IL-22RA1) expression in chronic lymphocytic leukemia

509

Plasma Interleukin-5 Levels Are Related to Antibodies Binding to Oxidized Low-Density Lipoprotein and to Decreased Subclinical Atherosclerosis Original Research Article

510

Plasma interleukin-6 is associated with psychological coronary risk factors: Moderation by use of multivitamin supplements

511

Plasma intrusion above Mars crustal fields—Mars Express ASPERA-3 observations

512

Plasma ion composition measurements for Europa

513

Plasma Iron Indices in Pregnant Women Referred to the University of Abuja Teaching Hospital, Nigeria

514

Plasma iron is associated with lipid peroxidation in an elderly population

515

PLASMA IRON IS ASSOCIATED WITH LIPID PEROXIDATION IN WOMEN

516

Plasma irradiation effects in phthalocyanine films

517

Plasma jet imaging by CCD technology in rapid mold manufacturing

518

Plasma jet impacts on Citrinin production in isolates belonging to Penicillium Spp.

519

Plasma jet treatment of five polymers at atmospheric pressure: surface modifications and the relevance for adhesion

520

Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease

521

Plasma l-arginine is markedly reduced in pregnant women affected by preeclampsia

522

Plasma LDL subtype distribution in patients with or without coronary stenosis

523

Plasma lens experiment at the final focus test beam

524

Plasma lens experiment at the final focus test beam

525

Plasma lens focusing and plasma channel transport for heavy ion fusion

526

Plasma lens formation in eγ and γγ colliders

527

Plasma leptin and adiponectin concentrations in postmenopausal women with breast cancer following aerobic exercise

528

Plasma Leptin and its Relationship with Lipid Peroxidation and Nitric Oxide in Obese Female Patients with or without Hypertension

529

Plasma leptin and prognosis in patients with established coronary atherosclerosis Original Research Article

530

Plasma Leptin Concentration in Cord Blood: Relationship to the Degree of Preeclampsia and Placental Weight

531

Plasma leptin concentration in migraine; the relationship with orexinergic nerve function

532

Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry

533

Plasma leptin concentrations during the reproductive cycle in the native Thai chicken (Gallus domesticus)

534

Plasma leptin concentrations in obese children: changes during 4-mo periods with and without physical training

535

PLASMA LEPTIN CONCENTRATIONS IN PRETERM INFANTS WITH RETINOPATHY OF PREMATURITY (ROP)

536

Plasma leptin in growing lambs as a potential predictor for carcass composition and daily gain

537

Plasma leptin levels and inflammation biomarkers in well nourished and malnourished haemodialysed patients

538

Plasma leptin levels in children with cyanotic and acyanotic congenital heart disease and correlations with growth parameters

539

Plasma leptin levels in patients with burn injury: a preliminary report

540

Plasma leptin, ghrelin and adiponectin concentrations in young fit racehorses versus mature unfit standardbreds

541

Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease

542

Plasma Level Monitoring of Oxcarbazepine in Epileptic Patients

543

Plasma level of adhesion molecules in patients suffering from stable and unstable angina

544

Plasma Level of Antioxidant Vitamins and Lipid Peroxidation in Breast Cancer Patients

545

Plasma Level of Glucagon-like Peptide 1 in Obese Egyptians with Normal and Impaired Glucose Tolerance

546

Plasma Level of miR-5193 as a Novel Biomarker for Diagnosis of HBV-Related Hepatocellular Carcinoma

547

Plasma Level of miRNA7, miRNA409 and miRNA93 as Potential Biomarkers for Colorectal Cancer

548

Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus

549

Plasma Level of Oxidized Low- Density Lipoprotein in Macroalbuminuric Type 2 Diabetic Patients versus Normoalbuminuric Group

550

Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin Original Research Article

551

Plasma level of trace elements in patients with oral lichen planus

552

Plasma level of vitamin C in women with pre-eclampsia in Ardabil, Iran

553

Plasma levels and hepatic mRNA expression of transforming growth factor-β1 in patients with fulminant hepatic failure

554

Plasma levels and profiles of dioxin and dioxin-like compounds in Ontario Great Lakes anglers

555

Plasma levels of 15-F2t-isoprostane in newborn infants are affected by mode of delivery

556

Plasma levels of 8-epiPGF2α, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer’s disease

557

Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy

558

Plasma levels of a low-dose constant-rate-infusion of ketamine and its effect on single and repeated nociceptive stimuli in conscious dogs

559

Plasma levels of adiponectin and soluble thrombomodulin in hypothyroid patients with normal thyroid function following levothyroxine replacement therapy

560

Plasma levels of adrenomedullin in patients with mitral stenosis, , ,

561

Plasma Levels of Adrenomedullin in Primary and Secondary Pulmonary Hypertension in Patients <20 Years of Age

562

Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease

563

Plasma Levels of Anabolic Hormones in Suckling Lambs are Affected by Late Gestational Nutrition

564

Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: An epidemiological study

565

Plasma levels of atrial natriuretic peptide and of other vasoconstricting hormones in patients with chronic heart failure: relationship to exercise capacity

566

Plasma levels of atrial natriuretic peptide in severe burn injury

567

Plasma levels of beta-amyloid (1–42) in Alzheimerʹs disease and mild cognitive impairment

568

Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis, ,

569

Plasma Levels of Brain Natriuretic Peptide in Children With Left-To-Right Shunt Before and After Cardiac Surgery

570

Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise

571

Plasma levels of chemokines during leprosy specific treatment

572

Plasma levels of copper, manganese and selenium in an adult population in southern Spain: Influence of age, obesity and lifestyle factors Original Research Article

573

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis

574

Plasma levels of DDT and their association with reproductive hormones in adult men from northern Thailand

575

Plasma levels of endothelin-1 and thrombomodulin in burn patients

576

Plasma levels of endothelin-1 at rest and after exercise in patients with moderate congestive heart failure

577

Plasma levels of fibrinogen as a pathogenic factor or risk indicator of atherosclerosis

578

Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity

579

Plasma levels of heat shock protein 72 (HSP72) and β-endorphin as indicators of stress, pain and prognosis in horses with colic

580

Plasma Levels of IFN-γ, IL-4, IL-6 and IL-17 in HIV-Positive Patients With Oral Candidiasis

581

Plasma levels of IL-6 and TNF-α in patients with esophageal cancer

582

Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatment

583

Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease

584

Plasma levels of interlukin-4 and Interferon- in patients with chronic or healed cutaneous leishmaniasis

585

Plasma levels of leptin and visfatin in rheumatoid arthritis patients; is there any relationship with joint damage?

586

Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment

587

Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits

588

Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome

589

Plasma levels of m-chlorophenylpiperazine following single oral dose administration of m-chlorophenylpiperazine and trazodone in human volunteers

590

Plasma Levels of MicroRNA-146a-5p, MicroRNA-24-3p, and MicroRNA-125a-5p as Potential Diagnostic Biomarkers for Rheumatoid Arthris

591

Plasma levels of miR-21, miR-150, miR-423 in patients with lupus nephritis

592

Plasma Levels of miR-27a, miR-130b, and miR-301a in Polycystic Ovary Syndrome

593

Plasma levels of miR-29a and miR-146a in relation to carotid intima media thickness measurement for detection of carotid atherosclerosis

594

Plasma levels of norepinephrine and expression levels of ß2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease

595

Plasma levels of N-telopeptide of Type I collagen in periodontal health, disease and after treatment

596

Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction

597

Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques

598

Plasma levels of parathyroid hormone that induce anabolic effects in bone of ovariectomized rats can be achieved by stimulation of endogenous hormone secretion

599

Plasma levels of resistin-like molecule beta in humans

600

Plasma levels of sex steroids (testosterone, progesterone and 17β-estradiol) in Rohu Carp Labeo rohita broodstock from Khuzestan, Iran

601

Plasma levels of soluble endothelial protein C-receptor in patients with β-thalassemia

602

Plasma levels of soluble Fas during treatment of chronic hepatitis C patients with interferon alpha

603

Plasma Levels of Soluble Tie2 and Vascular Endothelial Growth Factor Distinguish Critical Limb Ischemia From Intermittent Claudication in Patients With Peripheral Arterial Disease Original Research Article

604

Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission

605

Plasma Levels of Soluble Tumor Necrosis Factor Receptor Type I During the Acute Phase Following Complicated Myocardial Infarction Predicts Survival in High-Risk Patients Original Research Article

606

Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity

607

Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. physicians

608

Plasma Levels of the Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 are Elevated in Patients with Acute Myocardial Infarction

609

Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects

610

Plasma levels of thrombomodulin in pulmonary hypertension

611

Plasma Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Correlated With the Presence of Transplant Coronary Artery Disease in Cardiac Transplant Recipients

612

Plasma Levels of Troponin T After Electrical Cardioversion of Atrial Fibrillation and Flutter

613

Plasma levels of type II phospholipase A2 and nitrite/nitrate in patients with burns

614

Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, flt1, in haematological cancers: A comparison with breast cancer

615

Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension

616

Plasma levels of vascular endothelial growth factor and its soluble receptor in non-alcoholic fatty liver disease

617

Plasma Levels of Vascular Endothelial Markers in Obstructive Sleep Apnea

618

Plasma Levels of Viro-Immunological Markers in HIV-Infected and Noninfected Ethiopians: Correlation with Cell Surface Activation Markers

619

Plasma levels of vitamin E in Parkinsonʹs disease

620

Plasma levels of vitellogenin and eggshell zona radiata proteins in 4-nonylphenol and o,p′-DDT treated juvenile Atlantic salmon (Salmo salar)

621

Plasma levels of β-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine

622

Plasma LH concentrations after administration of human chorionic gonadotropin to estrous mares

623

Plasma Liner with an Intermediate Heavy Shell and Thermal Pressure Drive

624

Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension

625

Plasma lipid changes after supplementation with (beta)-glucan fiber from yeast

626

Plasma lipid levels in Alzheimer’s disease patients treated by Donepezil hydrochloride: a cross-sectional study

627

Plasma lipid levels in patients with acute bacterial infections

628

Plasma Lipid Levels in Patients with Cataract, with and without Pseudoexfoliation Syndrome

629

Plasma lipid modifications in elderly people after administration of two virgin olive oils of the same variety (Olea europaea var. hojiblanca) with different triacylglycerol composition

630

Plasma lipid oxidation and susceptibility of low-density lipoproteins to oxidation in male patients with stable coronary artery disease

631

Plasma lipid pattern and red cell membrane structure in β-thalassemia patients in Jakarta

632

Plasma Lipid Peroxidation and Total Antioxidant Status among Dyslipidaemic and Hypertensive Nigerians with High Risk of Coronary Heart Disease

633

Plasma lipid profile and coronary artery disease in Brazilian hemodialysis patients

634

Plasma Lipid Profile in Non-Diabetic Rats Treated with Extracts of Triplochiton Scleroxylon K. Schum

635

Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan — a unique experience Original Research Article

636

Plasma lipid regulatory effect of compounded freshwater clam hydrolysate and Gracilaria insoluble dietary fibre

637

Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment

638

Plasma lipids and apolipoproteins in a population of Orang Asli (‘aboriginesʹ) from West Malaysia

639

Plasma lipids and cardiovascular risk: a POSCH report

640

Plasma lipids and their role in disease, Edited by Philip J. Barter and Kerry-Anne Rye, Harwood Academic Publishers, 1999. ISBN: 90-5702-466-7; US$120

641

Plasma lipids are altered in Gaucher disease: Biochemical markers to evaluate therapeutic intervention

642

Plasma lipids relationship with results of Oral Glucose Challenge Test in pregnancy

643

Plasma lipids, clotting factors and cardiovascular risk

644

Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity

645

Plasma lipoprotein alterations in patients with chronic hepatocellular liver disease re sulting from alcohol abuse: effects of alcohol intake cessa tion : Camps J.; Pizarro, I.; Prats, E.; La Ville A.; Turner, P. R.; Masana, L.; Joven, J. J. Hepatol. 20:7

646

Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in β-thalassemia

647

Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin Original Research Article

648

Plasma lipoprotein fatty acids are altered by the positional distribution of fatty acids in infant formula triacyiglycerols and human milk

649

Plasma lipoprotein lipase, hepatic lipase activities, VLDL, LDL compositions at different times of hemodialysis

650

Plasma lipoprotein responses to enzyme-replacement in Gaucherʹs disease

651

Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

652

Plasma Lipoprotein-associated Phospholipase A2 Is Inversely Correlated with Proprotein Convertase Subtilisin-kexin Type 9

653

Plasma Lipoproteins and Atherosclerosis: Accomplishments and Opportunities

654

Plasma lipoproteins and incidence of non-insulin-dependent diabetes mellitus in Pima Indians: protective effect of HDL cholesterol in women

655

Plasma low-density lipoprotein immobilized silica as stationary phase in nano-liquid chromatography

656

Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: A randomized prospective study

657

Plasma Malondialdehyde and Obesity: Is there a Relationship?

658

Plasma malondialdehyde is induced by smoking: a study with balanced antioxidant profiles

659

Plasma mannan-binding lectin kills microorganisms

660

Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats

661

Plasma maser effect in magnetosphere plasma associated with MHD turbulence

662

Plasma material interaction studies on low activation materials used for plasma facing or blanket component

663

Plasma Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-2, and CD40 Ligand Levels in Patients With Stable Coronary Artery Disease

664

Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study

665

Plasma melatonin and cortisol in patients with obsessive–compulsive disorder: relationship with axillary temperature, physical activity, and clinical symptoms

666

Plasma melting and useful application of molten slag

667

Plasma membrane cholesterol plays a critical role in the Salmonella-induced anti-inflammatory response in intestinal epithelial cells

668

Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis

669

Plasma Membrane Depolarization Induced by Abscisic Acid in Arabidopsis Suspension Cells Involves Reduction of Proton Pumping in Addition to Anion Channel Activation, Which Are Both Ca2+ Dependent

670

Plasma membrane depolarization reduces nitric oxide (NO) production in P388D.1 macrophage-like cells during Leishmania major infection

671

Plasma membrane depolarization-activated calcium channels, stimulated by microtubule-depolmerizing drugs in wild-type Arabidopsis thaliana protoplasts, display constitutively large activities and a longer half-life in ton 2 mutant cells affected in the or

672

Plasma membrane functionalization using highly fusogenic immune activator liposomes

673

Plasma membrane H+-ATPase, succinate and isocitrate dehydrogenases activities of vessel-associated cells in walnut trees

674

Plasma membrane ion channels in suicidal cell death

675

Plasma Membrane Is the Primary Site of Localization of the Nonactivated Estrogen Receptor in the Goat Uterus: Hormone Binding Causes Receptor Internalization

676

Plasma membrane lipid alterations induced by cold acclimation and abscisic acid treatment of winter wheat seedlings differing in frost resistance

677

Plasma membrane NADH oxidase is gravi-responsive

678

Plasma membrane NADH oxidase of maize roots responds to gravity and imposed centrifugal forces

679

Plasma membrane permeabilization by trains of ultrashort electric pulses

680

Plasma Membrane Receptors for Exopolysaccharides of the Ring Rot Causal Agent in Potato Cells

681

Plasma Membrane Redox System in the Erythrocytes of Rowers: Pilot Study

682

Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes

683

Plasma Membrane Reshaping during Endocytosis Is Revealed by Time-Resolved Electron Tomography

684

Plasma membrane segregation during T cell activation: probing the order of domains

685

Plasma membrane transport in context — making sense out of complexity

686

Plasma membrane γ-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells

687

Plasma membrane γ-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells

688

Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age

689

Plasma Membrane-porating Domain in Poliovirus 2B Protein. A Short Peptide Mimics Viroporin Activity

690

Plasma metabolism of apoB-containing lipoproteins in patients with hepatic lipase deficiency

691

Plasma Metabolite Profiles of Healthy Volunteers after Administration of a Thai Herbal Formula for Dizziness

692

Plasma metabolites and nitrogen balance in Lama glama associated with forage quality at altitude

693

Plasma Metalloproteinase-12 and Tissue Inhibitor of Metalloproteinase-1 Levels and Presence, Severity, and Outcome of Coronary Artery Disease

694

Plasma met-enkephalin levels: its relationship with age and type of headache

695

Plasma met-enkephalin, β-endorphin and leu-enkephalin levels in human hepatic encephalopathy

696

Plasma methane conversion in the presence of carbon dioxide using dielectric-barrier discharges

697

Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia Original Research Article

698

Plasma microcirculation in alveolar capillaries: Effect of parachute-shaped red cells on gas exchange

699

Plasma microRNA profiles for bladder cancer detection

700

Plasma microRNA profiles for bladder cancer detection

701

Plasma microRNAs as non-invasive biomarkers in bovine endometritis caused by Gram-negative and Gram-positive bacteria

702

Plasma mixing as a cause of solar wind magnetic field variations Original Research Article

703

Plasma modeling for position and current control in FTU

704

Plasma modelisation and control for laser dismantling

705

Plasma modelling of matrix assisted UV laser desorption ionisation (MALDI)

706

Plasma Modes of Low-Dimensional Electron Systems over a Helium Film

707

Plasma modification of polycarbonates

708

Plasma modification of polylactic acid in a medium pressure DBD

709

Plasma modification of polypropylene surfaces and its alloying with styrene in situ

710

Plasma modification of self-assembled structures of CoTMPP molecules

711

Plasma modifications of porous PEEK–WC–PU membranes Original Research Article

712

Plasma modified polymers as a support for enzyme immobilization 1.: Allyl alcohol plasma

713

Plasma modified polymers as a support for enzyme immobilization II. Amines plasma

714

Plasma molding over surface topography: Simulation and measurement of ion fluxes, energies and angular distributions over trenches in RF high density plasmas

715

Plasma molybdenum reflects dietary molybdenum intake

716

Plasma multivariable robust control system design and simulation for a thermonuclear tokamak-reactor

717

Plasma Myeloperoxidase Activity and Apolipoprotein A-1 Expression in Chronic Hepatitis B Patients

718

Plasma Myeloperoxidase Levels in Patients With Chronic Heart Failure

719

Plasma n-3 and n-6 polyunsaturated fatty acids association with blood pressure level in healthy males

720

Plasma nanostructuring of porous polymer membranes

721

Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation

722

Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction

723

Plasma Nesfatin-1 and Insulin Resistance Changes Immediately After Circuit-Resistance Exercise and During Recovery Periods in Healthy Men

724

Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals

725

Plasma neuropeptide Y and total- and LDL-cholesterol are closely correlated in women without evident relation to the metabolic syndrome.

726

Plasma Neuropeptide Y Concentrations in Combat Exposed Veterans: Relationship to Trauma Exposure, Recovery from PTSD, and Coping

727

Plasma neuropeptide-Y concentrations in humans exposed to military survival training

728

Plasma neurotransmitters, blood pressure, and heart rate during supine resting, orthostasis, and moderate exercise in dysthymic depressed patients

729

Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients

730

Plasma Neutrophil Gelatinase Associated Lipocalin in Neonates With and Without Sepsis

731

Plasma neutrophil gelatinase-associated lipocalin (NGAL) and plasma cystatin C (CysC) as biomarker of acute kidney injury after cardiac surgery

732

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker for Prediction of 3-Month Graft Survival after Kidney Transplantation

733

Plasma Neutrophil Gelatinase–Associated Lipocalin Is Independently Associated With Cardiovascular Disease and Mortality in Community-Dwelling Older Adults: The Rancho Bernardo Study

734

Plasma Niobium Surface Alloying of Pure Titanium and its Oxidation at 900 °C

735

Plasma Nitric Oxide and Acute Phase Proteins after Moderate and Prolonged Exercises

736

Plasma nitric oxide and leptin values in patients with olanzapine-induced weight gain

737

Plasma nitric oxide level in heart failure secondary to left ventricular diastolic dysfunction

738

Plasma nitric oxide levels and the expression of P-selectin on platelets in preeclampsia

739

Plasma nitridation of a novel Ni–10.8 wt.%Cr nanocomposite Original Research Article

740

Plasma nitridation of aluminized high purity iron

741

Plasma nitridation of aluminized high purity iron Original Research Article

742

Plasma nitridation of Ge(100) surface studied by scanning tunneling microscopy

743

Plasma nitrided and TiCN coated AISI H13 steel by pulsed dc PECVD and its application for hot-working dies

744

Plasma nitrided austenitic stainless steels for automotive hydrogen applications

745

Plasma nitriding and in situ characterisation of aluminium

746

Plasma nitriding and nitrocarburising of sintered FeCrMo and FeCrMoC alloys

747

Plasma Nitriding Behavior of DIN 1.2344 Hot Work Tool Steel

748

Plasma nitriding behavior of low carbon binary alloy steels

749

Plasma nitriding behavior of Ti6Al4V orthopedic alloy

750

Plasma nitriding of 316L austenitic stainless steel: Experimental investigation of fatigue life and surface evolution

751

Plasma nitriding of 42CrMo low alloy steels at anodic or cathodic potentials

752

Plasma nitriding of 90CrMoV8 tool steel for the enhancement of hardness and corrosion resistance

753

Plasma nitriding of AISI 304 austenitic stainless steel with pre-shot peening

754

Plasma nitriding of AISI 304 stainless steel: Role of surface mechanical attrition treatment

755

Plasma nitriding of AISI 316L austenitic stainless steels at anodic potential

756

Plasma nitriding of Al alloys by DC glow discharge

757

Plasma nitriding of austenitic stainless steel in N2 and N2–H2 dc pulsed discharge

758

Plasma nitriding of Fe-Cr-Mo sintered steels

759

Plasma nitriding of Fe-Cr-Mo sintered steels

760

Plasma nitriding of low alloy steels at floating and cathodic potentials

761

Plasma nitriding of plastic mold steel to increase wear- and corrosion properties

762

Plasma nitriding of sintered AISI 316L at several temperatures

763

Plasma nitriding of Ti6Al4V alloy and AISI M2 steel substrates using D.C. glow discharges under a triode configuration

764

Plasma nitriding to selective laser sintering parts made of SCM430 powder

765

Plasma nitriding using high H2 content gas mixtures for a cavitation erosion resistant steel

766

Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans

767

Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals

768

Plasma nitrite reserve and endothelial function in the human forearm circulation

769

Plasma nitrites as an indicator of nitric oxide production: Unchanged production or reduced renal clearance in preeclampsia?

770

Plasma Nitroso Compounds Are Decreased in Patients With Endothelial Dysfunction Original Research Article

771

Plasma nitrosulfurizing techniques for low friction coefficient with H2S and C3H8 gas addition

772

Plasma non-cholesterol sterols

773

Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder

774

Plasma norepinephrine and prediction of outcome in major depressive disorder

775

Plasma norepinephrine kinetics in patients with posttraumatic stress disorder

776

Plasma norepinephrine, myocardial damage and left ventricular systolic function in Chagasʹ heart disease

777

Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression

778

Plasma N-Terminal B-Type Natriuretic Peptide as an Indicator of Long-Term Survival After Acute Myocardial Infarction: Comparison With Plasma Midregional Pro-Atrial Natriuretic Peptide: The LAMP (Leicester Acute Myocardial Infarction Peptide) Study Origin

779

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction

780

Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea

781

Plasma N-terminal pro-brain natriuretic peptide level as a marker of adverse outcome in patients with co-existing diabetes, chronic kidney disease and heart failure

782

Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention

783

Plasma N-Terminal Prohormone Brain Natriuretic Peptide as a Marker for Postoperative Cardiac Events in High-Risk Patients Undergoing Noncardiac Surgery

784

Plasma NT-PRO BNP concentrations are associated with ambulatory blood pressure in black hypertensive patients with normal systolic function on echocardiography

785

Plasma NT-pro BNP Concentrations in Patients with Hypertensive Chronic Kidney Disease

786

Plasma Obestatin Concentrations Are Negatively Correlated with Body Mass Index, Insulin Resistance Index, and Plasma Leptin Concentrations in Obesity and Anorexia Nervosa

787

Plasma obestatin, estradiol, and liver ATP concentrations in response to endurance exercise training at different durations in male rats

788

Plasma oestradiol and progesterone during early pregnancy in the cow and the effects of treatment with buserelin

789

Plasma oestrogen and the regulation of egg weight in laying hens by dietary fats

790

Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking

791

Plasma oestrone-fatty acid ester levels are correlated with body fat mass in humans

792

Plasma OLC is elevated in mild experimental uremia but is not associated with hypertension

793

Plasma operation and control

794

Plasma operation with tungsten tiles at the central column of ASDEX Upgrade

795

Plasma optical emission spectroscopy diagnostic during amorphous silicon thin films deposition by Rf sputtering technique

796

Plasma oscillations in nanotubes and the Aharonov-Bohm effect for plasmons

797

Plasma osmolality in acute spontanious intra-cerebral hemorrhage: Does it influence hematoma volume and clinical outcome?

798

Plasma Osteopontin and Interleukin-18 Levels in Patients with Systemic Lupus Erythematosus: Association with Disease Activity and Lupus Nephritis

799

Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma

800

Plasma osteopontin levels are associated with the presence and extent of coronary artery disease

801

Plasma Osteopontin Levels Are Higher in Patients With Primary Aldosteronism Than in Patients With Essential Hypertension

802

Plasma over-treatment effect on the MOCVD-TiN contact glue layer

803

Plasma oxidation of bilayered Y/Zr films

804

Plasma oxidation of the insulation layer in the magnetic tunneling junctions

805

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure

806

Plasma oxynitrocarburizing of 40Cr steel in an atmosphere of gasoline and air

807

Plasma oxysterol level in patients with coronary artery stenosis and its changes in response to the treatment with atorvastatin

808

Plasma Oxytocin Level and Sexual Dysfunction in Depressed Women Treated by Either Fluoxetine or Citalopram: a Pilot Clinical Trial

809

Plasma oxytocin levels in autistic children

810

Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: Their significances

811

Plasma parameter investigation during plasma-enhanced chemical vapor deposition of silicon-containing diamond-like carbon films

812

Plasma parameter measurements and deposition of a-Si:H thin films in pulsed ECR plasma.

813

Plasma parameters in pulsed laser-plasma deposition of thin films

814

Plasma parameters of an arc cathode spot at the low-current vacuum discharge

815

Plasma parameters of argon and argon/molecular gas mixture plasmas produced in microwave discharge

816

Plasma paraoxonase, sphingosine1phosphate, total sialic acid, and heat shock protein27 in the liver of the sheep naturally infected with Cysticercus tenuicollis: Evidence on pathological changes

817

Plasma particles dispersion based on Bogoyavlensky-Konopelchenko mathematical model

818

Plasma paste boronizing of AISI 8620, 52100 and 440C steels

819

Plasma PBDE and thyroxine levels in rats exposed to Bromkal or BDE-47 Original Research Article

820

Plasma penetration depth and mechanical properties of atmospheric plasma-treated 3D aramid woven composites

821

Plasma performance improvements with liquid lithium limiters in CDX-U

822

Plasma peroxidation and α-tocopherol levels in women fed different monoene oils

823

Plasma persistence of 2-aminothiazoline-4-carboxylic acid in rat system determined by liquid chromatography tandem mass spectrometry

824

PLASMA PHARMACOKINETICS AND MUSCLE DISPOSITION OF MARBOFLOXACIN IN CHICKENS

825

Plasma pharmacokinetics and tissue distribution study of physalin D in rats by ultra-pressure liquid chromatography with tandem mass spectrometry

826

Plasma pharmacokinetics of melamine and a blend of melamine and cyanuric acid in rainbow trout (Oncorhynchus mykiss)

827

Plasma pharmacokinetics of pioglitazone following oral or intravenous administration in Holstein cows

828

Plasma pharmacokinetics of warfarin enantiomers in cats

829

Plasma phase oxidation during preparation of oxide superconducting and ferroelectric thin films using pulsed laser deposition

830

Plasma phospholipid fatty acid pattern in severe liver disease

831

Plasma phospholipid fatty acid status and depressive symptoms: Association only present in the clinical range

832

Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus

833

Plasma pinch for final focus and transport

834

Plasma pinch for final focus and transport

835

Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity

836

Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis

837

Plasma plume induced during ArF laser ablation of hydroxyapatite

838

Plasma plume photography and spectroscopy of Fe—Oxide materials

839

Plasma polymer coating in a triode glow discharge

840

Plasma polymer films and their future prospects

841

Plasma polymer films as an alternative to (PSS-PAH)n or (PSS-PDADMAC)n films to retain active enzymes in exponentially growing polyelectrolyte multilayers

842

Plasma polymer thin film depositions to regulate gas permeability through nanoporous track etched membranes

843

Plasma polymerisation of methylphenylsilane

844

Plasma polymerization in a microcapillary using an atmospheric pressure dielectric barrier discharge

845

Plasma polymerization of amine-containing thin films and the studies on the deposition kinetics

846

Plasma polymerization of C4Cl6 and C2H2Cl4 at atmospheric pressure

847

Plasma polymerization of hexamethyldisiloxane: Investigation of the effect of carrier gas related to the film properties

848

Plasma polymerization of hybrid organic–inorganic monomers in an atmospheric pressure dielectric barrier discharge

849

Plasma polymerization of styrene with carbon dioxide under glow discharge conditions

850

Plasma polymerization using a constricted anode plasma source

851

Plasma polymerized allylamine films deposited on 316L stainless steel for cardiovascular stent coatings

852

Plasma polymerized barrier films on membranes for direct methanol fuel cells

853

Plasma polymerized ferrocene films

854

Plasma polymerized hexamethyl disiloxane in adhesion applications

855

Plasma polymerized hexamethyldisiloxane (HMDS) barrier layers

856

Plasma polymerized TEOS films for nanochannels formation and sensor development

857

Plasma polymerized thiophene: molecular structure and electrical properties

858

Plasma polymers with chemically defined structures in contact with metals

859

Plasma polyunsaturated fatty acids and periodontal recovery in Taiwanese with periodontitis: A significant relationship

860

Plasma porphyrin concentrations in chronic renal failure

861

Plasma position and current control system enhancements for the JET ITER-like wall

862

Plasma position measurement on the Novillo tokamak

863

Plasma post-heparin lipase activities in the HERITAGE family study: the reproducibility, gender differences, and associations with lipoprotein levels

864

Plasma post-oxidation mechanisms of nitrided ferrous alloys

865

Plasma post-oxidation of nitrocarburized SUM 24L steel

866

Plasma post-oxidation process for nitrocarburized layer

867

Plasma potential fluctuations and large quasi-coherent modes observed by a heavy ion beam probe on the JIPP T-IIU tokamak

868

Plasma Potential Measurements by the Heavy Ion Beam Probe Diagnostic in Fusion Plasmas: Biasing Experiments in the TJ-II Stellarator and T-10 Tokamak

869

Plasma powder as cold-set binding agent for meat system: Rheological and Raman spectroscopy study

870

Plasma power source based on a catalytic reaction of atomic hydrogen measured by water bath calorimetry

871

Plasma preconditioning of sapphire substrate for GaN epitaxy

872

Plasma preconditioning of sapphire substrate for GaN epitaxy

873

Plasma Prekallikrein as a Risk Factor for Diabetic Retinopathy

874

Plasma preparation of coal to combustion in power boilers

875

Plasma pressure and the field-aligned currents in the magnetosphere Original Research Article

876

Plasma pressure distribution in the inner magnetosphere and the applicability of Dessler-Parker-Sckopke relation to storm time magnetic disturbance description Original Research Article

877

Plasma pre-treatment and TiO2 coating of PMMA for the improvement of antibacterial properties

878

Plasma pretreatment of the Cu seed layer surface in Cu electroplating

879

Plasma pretreatments for Cu-MOCVD

880

Plasma printing: patterned surface functionalisation and coating at atmospheric pressure

881

Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure

882

Plasma Procalcitonin Is Useful for Predicting the Severity of Acute Cholecystitis

883

Plasma Procalcitonin Levels in Chronic Haemodialysis Patients

884

Plasma process for development of a bulk heterojunction optoelectronic device: A highly sensitive UV detector

885

Plasma processes and film deposition using tetraethoxysilane

886

Plasma processes for wide fabric, film and non-wovens

887

Plasma processes in pulsar magnetospheres

888

Plasma processing for inducing bioactivity in stainless steel orthopaedic screws

889

Plasma processing for surface modification of trivalent chromium as alternative to hexavalent chromium layer

890

Plasma processing of AISI 304 stainless steel using radio frequency hollow cathode discharge

891

Plasma processing of interstellar PAHs into solar system kerogen

892

Plasma processing of materials for medical applications

893

Plasma processing of the Si(0 0 1) surface for tuning SPR of Au/Si-based plasmonic nanostructures

894

PLASMA PROCESSING OF THIN FILMS OF HIGH TEMPERATURE SUPERCONDUCTORS: DEPOSITION METHODS AND GROWTH ASPECTS

895

PLASMA PROCESSING OF THIN FILMS OF HIGH TEMPERATURE SUPERCONDUCTORS: DEPOSITION METHODS AND GROWTH ASPECTS

896

Plasma processing: a step towards the production of new grades of carbon black Original Research Article

897

Plasma profile and shape optimization for the advanced tokamak power plant, ARIES-AT

898

Plasma profiles and flows in the high-field side scrape-off layer in Alcator C-Mod

899

Plasma profiles in the inner divertor of ASDEX Upgrade

900

Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1

901

Plasma Profiles of Progesterone and Conceptus Proteins in Cows with Spontaneous Embryonic/Fetal Mortality as Diagnosed by Ultrasonography

902

Plasma progesterone changes and length of oestrous cycle in Rusa Deer (Rusa timorensis)

903

Plasma progesterone concentration depends on sampling site in pigs

904

Plasma progesterone concentration in relation to ovulation rate and embryo yield in Chios ewes superovulated with PMSG

905

Plasma progesterone concentrations during early pregnancy in spring- and autumn-bred ewes

906

Plasma progesterone concentrations in the mid-luteal phase are dependent on luteal size, but independent of luteal blood flow and gene expression in lactating dairy cows

907

Plasma progesterone in alpaca (Lama pacos) during pregnancy, parturition and early postpartum

908

Plasma prolactin response to d-fenfluramine in obsessive—compulsive patients before and after fluvoxamine treatment

909

Plasma prolactin, growth hormone and progesterone concentrations in pseudopregnant, hysterectomized and pregnant goats

910

Plasma properties above coronal active regions inferred from SOHO/UVCS and radio spectrograph observations

911

Plasma properties and stoichiometry of laser-deposited BiSrCaCuO thin films

912

Plasma properties from the multi-wavelength analysis of the November 1st 2003 CME/shock event

913

Plasma properties of a new surface-wave-sustained plasma source under the conditions of depositing DLC films

914

Plasma protein adsorption pattern on characterized ceramic biomaterials

915

Plasma Protein and Aggregation Changes in Diabetic Patients

916

Plasma Protein and Soy Fiber Content Effect on Bologna Sausage Properties as Influenced by Fat Level

917

Plasma Protein Binding and Blood-to-Plasma Ratios of Atractylodin and β-Eudesmol, the Bioactive Compounds from Atractylodes lancea (Thunb.) D.C.

918

Plasma protein binding study of oxybutynin by high-performance frontal analysis

919

Plasma protein glycation status in Pakistan type 2 diabetic patients with or without nephropathy

920

Plasma Protein Hydroperoxides During Aging in Humans: Correlation with Paraoxonase 1 (PON1) Arylesterase Activity and Plasma Total Thiols

921

Plasma Protein Lipofuscin-like Fluorophores in Men with Coronary Artery Disease Treated with Statins

922

Plasma Protein Profile of Lactating Women from Two Primary Health Centers in Jakarta, Indonesia

923

Plasma protein therapies: current and future perspectives

924

Plasma protein variations in monozygotic twins discordant for schizophrenia

925

Plasma Proteins in Acute and Chronic Lung Disease of the Newborn

926

Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): Up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer

927

Plasma pyridoxal 5′-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease

928

Plasma pyridoxal 5′-phosphate is a significant indicator of immune responses in the mechanically ventilated critically ill

929

Plasma Pyridoxal 5´-Phosphate Level in Children with Intractable and Controlled Epilepsy

930

Plasma quercetin metabolites: structure–antioxidant activity relationships

931

Plasma radiation distribution and radiation loads onto the vessel during transient events in JET

932

Plasma reactions of N2O on hydrogenated amorphous carbon films by PECVD

933

Plasma recovery after various events in HT-7 superconducting tokamak

934

Plasma reduced folates, reproductive performance, and conceptus development in sows in response to supplementation with oxidized and reduced sources of folic acid

935

Plasma Reforming of Aliphatic Hydrocarbons With CO2

936

Plasma reforming of bio-ethanol for hydrogen rich gas production

937

Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases

938

Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects Original Research Article

939

Plasma renin activity and insulin resistance in African American and white children: the Bogalusa Heart Study

940

Plasma Renin Activity and Plasma Prorenin Are Not Suppressed in Hypertensives Surviving to Old Age

941

Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types

942

Plasma renin activity in the emergency department and its independent association with acute myocardial infarction

943

Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients

944

Plasma renin activity predicts myocardial infarction/revascularization among hypertensive patients

945

Plasma Renin Activity: A Risk Factor for Myocardial Infarction in Hypertensive Patients

946

Plasma resonance of silver nanoparticles deposited on the surface of submicron silica spheres

947

Plasma response models for current, shape and position control in JET

948

Plasma response to a single dose of dietary (beta)-cryptoxanthin esters from papaya (Carica papaya L.) or non-esterified (beta)-cryptoxanthin in adult human subjects: a comparative study

949

Plasma retinol and tocopherol levels in relation to demographic, lifestyle and nutritional factors of plant origin in Greece

950

Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: A three year longitudinal study

951

Plasma rich in growth factors in dogs: Two sides of the same coin

952

Plasma rotation and structure of the radial electric field in RFX

953

Plasma rotation under a driven radial current in a tokamak

954

Plasma S-100B protein in Chinese patients with schizophrenia: Comparison with healthy controls and effect of antipsychotics treatment

955

Plasma satellites of X-ray lines of ions in a picosecond laser plasma

956

Plasma scattering measurement using a submillimeter wave gyrotron (gyrotron FU-II) as a power source

957

Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis

958

Plasma scenarios, equilibrium configurations and control in the design of FAST

959

Plasma secondary-neutral and secondary-ion mass spectrometry investigations on ceramic/copper powder pellets

960

Plasma seed priming in green cumin: physiological and developmental study

961

Plasma Selenium Concentration and Glutathione Peroxidase Activity in Breast Cancer Patients Before and After Chemotherapy

962

Plasma selenium concentrations in pregnant women in two countries with contrasting soil selenium levels

963

Plasma selenium in preterm and term infants during the first 12 months of life

964

Plasma Selenium Levels and Risk of Hepatocellular Carcinoma among Men with Chronic Hepatitis Virus Infection

965

Plasma Selenium Levels and Risk of Hepatocellular Carcinoma among Men with Chronic Hepatitis Virus Infection

966

Plasma selenium levels in healthy blood bank donors in the central-eastern part of Belgium

967

Plasma Selenium Measurements in Subjects from Areas with Contrasting Gastric Cancer Risks in Colombia

968

Plasma selenium status in a group of Australian blood donors and fresh blood components

969

Plasma selenium status in children with iron deficiency anemia

970

Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis

971

Plasma sequestration before cardiopulmonary bypass and cell saving contribute to improved outcome in high-risk cardiac surgical patients

972

Plasma Serotonin and Markers of Bone Formation and Bone Resorption in Hemodialysis Patients

973

Plasma sFas and sFas Ligand Levels in Patients With Thrombotic Thrombocytopenic Purpura and in Those With Disseminated Intravascular Coagulation

974

Plasma sheath behavior and ionic wind effect in electric field modified flames

975

Plasma sheet and magnetosheath plasma mixing in LLBL: Case study Original Research Article

976

Plasma sheet coefficient of diffusion: Predictions and observations Original Research Article

977

Plasma sheet heating during substorm and the values of the plasma sheet diffusion coefficient obtained on the base of interball/tail probe observations Original Research Article

978

Plasma sheet oscillations and their relation to substorm development: Cluster and double star TC1 case study Original Research Article

979

Plasma shield dynamics and target erosion in disruption simulation experiments

980

Plasma shielding effect in laser ablation of metallic samples and its influence on LIBS analysis

981

Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain

982

Plasma sialic-acid index of apolipoprotein J (SIJ): a new alcohol intake marker

983

Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function

984

Plasma soluble intercellular adhesion molecule-1 levels in coronary circulation in patients with unstable angina

985

Plasma Soluble Osteopontin Concentrations Are Increased in Patients With Rheumatic Mitral Stenosis and Associated With the Severity of Mitral Valve Calcium

986

Plasma source ion implantation using high-power pulsed RF plasma

987

Plasma spheroidization and high temperature stability of lanthanum phosphate and its compatibility with molten uranium

988

Plasma spheroidization of ceramic particles

989

Plasma spheroidization of iron powders in a non-transferred DC thermal plasma jet

990

Plasma spray coating of fly ash pre-mixed with aluminium powder deposited on metal substrates

991

Plasma spray deposition and characterization of strontium zirconate coatings

992

Plasma spray deposition and high temperature characterization of ZrB2–SiC protective coatings

993

Plasma spray deposition of Al-Al2O3 coatings doped with metal oxides: catalytic applications

994

Plasma spray deposition of ultra high temperature ceramics

995

Plasma spray formed near-net-shape MoSi2–Si3N4 bulk nanocomposites—structure property evaluation

996

Plasma spray forming

997

Plasma spray synthesis of La10(SiO4)6O3 as a new electrolyte for intermediate temperature solid oxide fuel cells

998

Plasma spray synthesis of nanomaterial powders and deposits

999

Plasma spray synthesis of nanomaterial powders and deposits

1000

Plasma spray synthesis of ultra-fine YSZ powder

بازگشت